Library

feed icon rss

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    ISSN: 1432-1041
    Keywords: enprofylline ; theophylline ; bronchial reactivity ; histamine inhalation test ; healthy volunteers ; pharmacokinetics ; bronchodilatation
    Source: Springer Online Journal Archives 1860-2000
    Topics: Chemistry and Pharmacology , Medicine
    Notes: Summary In a double blind, placebo controlled, crossover study the pharmacokinetics and acute effects of enprofylline and theophylline on airway reactivity during histamine challenge were investigated in 10 healthy volunteers. The pharmacokinetic parameters of enprofylline were (mean): elimination half-life 1.9 h, total body clearance 191.1 ml · kg−1 · h−1, volume of distribution 0.48 l · kg−1, and protein binding 49%. Bronchial reactivity in the histamine inhalation test was expressed as the concentration causing a 20% fall in FEV1.0 (PC20). Mean PC20 values were lowest after placebo and highest after theophylline with the enprofylline values in between. Only the difference in PC20 Safter placebo and theophylline was statistically significant (p〈0.05). At the time of determination of the PC20, the serum concentration of enprofylline was between 16.5 and 11.8 µmol/l, and that of theophylline was between 78.3 and 61.1 µmol/l. Adverse actions of enprofylline were nausea (3/10) and cardiovascular reactions (2/10), whereas theophylline mainly caused restlessness (3/10) and tremor (2/10). Thus enprofylline, in one-fifth of the serum concentration of theophylline cannot be regarded as equipotent in terms of bronchoprotection.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 2
    Electronic Resource
    Electronic Resource
    Springer
    European journal of clinical pharmacology 26 (1984), S. 491-498 
    ISSN: 1432-1041
    Keywords: theophylline ; computer simulation ; pharmacokinetics ; single-point dose prediction ; nomogram
    Source: Springer Online Journal Archives 1860-2000
    Topics: Chemistry and Pharmacology , Medicine
    Notes: Summary A dosage prediction method to estimate theophylline clearance and dose requirement was evaluated in 22 outpatients with partly reversible obstructive airways disease. The steady state theophylline dose required to achieve a target concentration (Css) was predicted using a single serum theophylline determination 8 h after a single oral test dose. In 17 nonsmoking patients a mean absolute deviation of 8.2% (range 0.0–21.7%) between predicted and observed Css was found, and in 5 smoking patients the mean deviation was 34.0% (range 2.2–53.8%). In 17 healthy smokers the single-point method was found to predict theophylline clearance at a sampling time of 8 h with a prediction error of 11.3 (range 0.8–25.3%) compared to the clearance determination using the area under the curve. In addition, a numerical simulation program to assess the influence of absorption, elimination and sampling time on predictive accuracy showed that the method could be successfully applied to a patient population with elimination rate constants between 0.07 1/h and 0.25 1/h, allowing a mean prediction error of 15%.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 3
    ISSN: 1435-1420
    Keywords: Key words ARDS ; tuberculosis ; pneumonia ; pregnancy ; Schlüsselwörter ARDS ; Tuberkulose ; Pneumonie ; Schwangerschaft
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Description / Table of Contents: Zusammenfassung Wir berichten über den Fall einer 17-jährigen Patientin, die in der 23. Schwangerschaftswoche an einem durch eine tuberkulöse Pneumonie verursachten „adult respiratory distress syndrome“ (ARDS) erkrankte. Nach Diagnosestellung und Einleitung einer antimykobakteriellen Chemotherapie und Steroidtherapie trat eine rasche Besserung ein, so daß die Patientin nach 5-tägiger Beatmung extubiert wurde. In der 37. Schwangerschaftswoche entband die Patientin eine Tochter, die innerhalb eines mehrwöchigen Beobachtungszeitraumes keine Tuberkulosesymptome zeigte.
    Notes: Summary We report about a 17 year old patient who survived an adult respiratory distress syndrome (ARDS) associated with tuberculous pneumonia in the 23rd week of pregnancy. After establishing the diagnosis and initiation of antituberculous and steroid treatment, the patient showed rapid improvement and was extubated after 5 days of ventilator treatment. In the 37th week of pregnancy, she delivered a daughter who showed no signs of tuberculosis after several weeks of observation.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 4
    Electronic Resource
    Electronic Resource
    Springer
    Intensivmedizin und Notfallmedizin 37 (2000), S. 374-379 
    ISSN: 1435-1420
    Keywords: Key words Hemoptysis – pulmonary bleeding – bronchoscopy – bronchial artery embolization ; Schlüsselwörter Hämoptoe – pulmonale Blutungen – Bronchoskopie – Bronchialarterienembolisation
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Description / Table of Contents: Zusammenfassung Massive intrapulmonale Blutungen sind ein bedrohliches Symptom, welche Patienten sofort zum Arzt führen. In dieser Situation sind die diagnostischen Möglichkeiten aus Zeitmangel beschränkt. Die Notfallversorgung ist notwendig um der lebensbedrohlichen Verlegung der Atemwege zu begegnen. Diese erfolgt nach den allgemeinen Regeln der Notfallmedizin. Zur effektiven Blutstillung muss zwischen lokalisierten und generalisierten Blutungsursachen unterschieden werden. Die Bronchoskopie ist indiziert, weil sie diese Differenzierung ermöglicht und die Blutung lokalisieren kann. Generalisierte pulmonale Blutungen sind meist durch systemische Erkrankungen bedingt. Sie werden entsprechend ihrer Pathogenese behandelt.¶   Die Bronchialarterienembolisation hat sich als effektives Verfahren zur Therapie lokalisierter Blutungen bewährt. Als ultima ratio gilt die chirurgische Resktion blutender Lungenanteile.
    Notes: Summary Massive intrapulmonary bleeding is an alarming symptom that causes the patient to see his doctor immediately. In this situation diagnostic possibilities are limited due to the lack of time. The immediate treatment of the patient is necessary due to the life threathening airway obstruction. Initial treatment is according to the principles of emergency medicine. In order to treat the hemorrhage effectively, it is essential to differentiate between localized and generalized causes. Bronchoscopy is able to differentiate these possibilities; furthermore it enables one to localize the site of the bleeding. Generalized pulmonary hemorrhage is mostly due to systemic diseases, which are treated according to the pathogenesis.¶   Bronchial artery embolization has proven to be effective in the therapy of localized pulmonary hemorrhage. Ultimately the surgical resection of bleeding parts of the lung may be indicated.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 5
    ISSN: 1434-9949
    Keywords: Rheumatoid Arthritis ; Skin Vessel Wall Immune Deposits ; Extra-articular Features ; Three-Year Follow-Up Study
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Summary Rheumatoid arthritis (RA) as a systemic disease can attack many other organs in addition to the joints. A variety of pathological lesions of the blood vessels are responsible for the extra-articular features (EAF). In the present study, we investigated firstly whether the presence of blood vessel changes in one organ—namely the skin—may indicate blood vessel pathology and, consequently, EAF in other organs. Secondly, we investigated the number of EAF in individual patients with RA, and observed whether this changed during the course of the disease. Fifty-one RA-patients (40 female, 11 male; ages had a mean of 49.5, minimum 19, maximum 73 years; mean duration of RA was 7.3, minimum 0.25, maximum 41 years) were included in the study. Punch biopsies from the posterior calf were examined immunohistologically for vessel wall immune deposits. Further, EAF were determined by means of instrumental clinical methods such as pulmonary function test, echocardiography, electromyography, and nerve conduction velocity measurement. At the first investigation 21/51 patients had skin vessel wall immune deposits (SVWID). Five patients—all showed SVWID at first investigation—died during the three-year investigation period, 10 patients could not be followed-up for unknown reasons; the skin biopsy of one patient could not be assessed. At the final investigation, we found SVWID in 11/35 patients. SVWID-positive patients had more EAF compared to SVWID-negative patients; this was true both, at the first investigation (1.85 EAF/patient vs 1.05 EAF/patient) and at the final investigation (1.91 EAF/patient vs 0.67 EAF/patient). However, if patients with and without SVWID at first investigation were followed-up independent of their belonging to SVWID-positive or SVWID-negative group at final investigation number of EAF did not change significantly in both patient groups. It can be concluded from these data that in RA-patients SVWID are poor indicators of prognosis regarding survival. Further, SVWID indicate a greater risk for presence of EAF. However, SVWID were not associated with an increase in the absolute number of EAF occuring during the period of observation in surviving patients.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 6
    ISSN: 1432-0843
    Keywords: Key words Dexniguldipine-HCl ; Phase I trial ; Pharmacokinetics
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Abstract  Dexniguldipine-HCl is a new dihydropyridine compound that exerts selective antiproliferative activity in a variety of tumor models and, in addition, has a high potency in overcoming multidrug resistance. The purpose of this trial was to determine the toxicity and pharmacokinetics of dexniguldipine and to establish a recommended dose for phase II trials. A total of 37 patients with cancer were treated with oral dexniguldipine in increasing doses for up to 7 days. The main parameters evaluated were subjective tolerance and laboratory and cardiovascular parameters (blood pressure and ECG). Blood samples were drawn for analysis of the drug’s pharmacokinetics. Dizziness and nausea were the major adverse events observed in seven patients, but episodes were generally mild and not clearly dose-related. Vomiting occurred in one patient. Hypotensive effects and orthostatic dysregulation were observed in some patients but were not considered to be dose-limiting. Therefore, no dose-limiting toxicity was found and the maximally tolerable dose could not be determined. Pharmacokinetic data showed wide interindividual variation and a dose-dependent increase in steady-state serum concentrations at doses of up to 1,000 mg daily, with no clear further increase being observed at higher doses. Consistently high concentrations were achieved with the 2,500-mg dose. Despite the lack of dose-limiting toxicity, higher doses of dexniguldipine do not appear to be useful for clinical evaluation because of the pharmacokinetic properties of the compound; therefore, 2,500 mg/day is recommended as the daily dose for phase II trials.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 7
    ISSN: 1432-0843
    Keywords: Dexniguldipine-HCl ; Phase I trial ; Pharmacokinetics
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Abstract Dexniguldipine-HCl is a new dihydropyridine compound that exerts selective antiproliferative activity in a variety of tumor models and, in addition, has a high potency in overcoming multidrug resistance. The purpose of this trial was to determine the toxicity and pharmacokinetics of dexniguldipine and to establish a recommended dose for phase II trials. A total of 37 patients with cancer were treated with oral dexniguldipine in increasing doses for up to 7 days. The main parameters evaluated were subjective tolerance and laboratory and cardiovascular parameters (blood pressure and ECG). Blood samples were drawn for analysis of the drug's pharmacokinetics. Dizziness and nausea were the major adverse events observed in seven patients, but episodes were generally mild and not clearly dose-related. Vomiting occurred in one patient. Hypotensive effects and orthostatic dysregulation were observed in some patients but were not considered to be dose-limiting. Therefore, no dose-limiting toxicity was found and the maximally tolerable dose could not be determined. Pharmacokinetic data showed wide interindividual variation and a dose-dependent increase in steady-state serum concentrations at doses of up to 1,000 mg daily, with no clear further increase being observed at higher doses. Consistently high concentrations were achieved with the 2,500-mg dose. Despite the lack of dose-limiting toxicity, higher doses of dexniguldipine do not appear to be useful for clinical evaluation because of the pharmacokinetics properties of the compound; therefore, 2,500 mg/day is recommended as the daily dose for phase II trials.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 8
    Electronic Resource
    Electronic Resource
    Springer
    Der Internist 39 (1998), S. 366-367 
    ISSN: 1432-1289
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 9
    Electronic Resource
    Electronic Resource
    Springer
    European archives of oto-rhino-laryngology and head & neck 227 (1980), S. 467-469 
    ISSN: 1434-4726
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Summary The tracheo-esophageal shunt has not to be created too wide because of the danger of aspiration; but narrow shunts require high intrathoracical pressure for phonation. In seven patients a pulmonary function test was done and then the mean air flow and the esophageal pressure during phonation were measured. In four of these patients we obtained sufficient data: one patient showed a shunt resistance of 35 cm H2O/l/s which is comparable to the phonatory resistance of a normal glottis. In the three other patients resistances were found being 10–80 times higher than the normal glottal resistance. In those two patients having the lowest and the highest shunt resistance, respectively, the change of blood pressure in the pulmonary artery during phonation was recorded by cardiac catheterisation. In the patient with low resistance the mean arterial pressure increased twofold, whereas the other one showed a sixfold increase. From these observations it is concluded that phonation with a Staffieri-shunt often does not only mean a considerable respiratory load, but also a cardiovascular stress in the sense of the Valsalva-maneuver. Therefore, chronic lung and heart diseases should be regarded as contraindications against a Staffieri-shunt.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 10
    ISSN: 1618-2650
    Source: Springer Online Journal Archives 1860-2000
    Topics: Chemistry and Pharmacology
    Notes: Conclusion All of the immunoassays tested were rapid and easy to perform. The precision of these tests was adequate and the results were comparable with those obtained by HPLC. The EMIT correlated best with HPLC and showed a high specificity. Normally encountered levels of other xanthines or uric acids apparently do not interfere with this assay.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...